Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Ropivacaine vs IV PCA for Post-VATS Pain
NCT01703351Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Oct 2012
- Primary completion
- Nov 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, randomised trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain and neuropathic pain (2 arms), sponsored by Yonsei University. Primary endpoint: Acute pain score (Visual Analogue Scale). Started Oct 2012; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative painneuropathic pain
Beyond the preview
Go deeper on NCT01703351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703351.